Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Chen

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Ejhaem|March 12, 2021
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamideBrendan L Mangan, Dilan Patel, Heidi Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell diseaseDilan A Patel, Nathalie Dhedin, Heidi Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimenStuart Salmon, Heidi Chen, Shuo Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Transplantation and Cellular Therapy|February 19, 2022
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic TransplantationAmeet Patel, Karina Wilkerson, Heidi Chen, et al.
Plos One|March 5, 2026
Chest drain REgular FLushing in ComplIcated parapneumonic EFfusions and empyemas: Study protocol for the RELIEF randomized controlled trialTaryn K Boyle, Jennifer D Duke, Gulmira Yermakhanova, et al.
Journal of Hematology|March 1, 2021
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantDilan A Patel, Karina A Mendoza, Heidi Chen, et al.
Cancers|September 28, 2023
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified IndividualsS M Jamshedur Rahman, Sheau-Chiann Chen, Yi-Ting Wang, et al.
Haematologica|September 22, 2018
Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignanciesJocelyn S Gandelman, Michael T Byrne, Akshitkumar M Mistry, et al.
Bone Marrow Transplantation|June 20, 2018
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapyC Amos Clark, Claudio A Mosse, Heidi Chen, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Ejhaem|March 12, 2021
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamideBrendan L Mangan, Dilan Patel, Heidi Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell diseaseDilan A Patel, Nathalie Dhedin, Heidi Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimenStuart Salmon, Heidi Chen, Shuo Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancerJeffrey M Albert, Adriana Gonzalez, Pierre P Massion, et al.
Transplantation and Cellular Therapy|February 19, 2022
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic TransplantationAmeet Patel, Karina Wilkerson, Heidi Chen, et al.
Plos One|March 5, 2026
Chest drain REgular FLushing in ComplIcated parapneumonic EFfusions and empyemas: Study protocol for the RELIEF randomized controlled trialTaryn K Boyle, Jennifer D Duke, Gulmira Yermakhanova, et al.
Journal of Hematology|March 1, 2021
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantDilan A Patel, Karina A Mendoza, Heidi Chen, et al.
Cancers|September 28, 2023
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified IndividualsS M Jamshedur Rahman, Sheau-Chiann Chen, Yi-Ting Wang, et al.
Haematologica|September 22, 2018
Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignanciesJocelyn S Gandelman, Michael T Byrne, Akshitkumar M Mistry, et al.
Bone Marrow Transplantation|June 20, 2018
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapyC Amos Clark, Claudio A Mosse, Heidi Chen, et al.
Pageof 21